Plasma miRNA-214 is a predictive candidate biomarker of progression speed in patients with ALS
Min‐Young Noh, Min‐Soo Kwon, Ki‐Wook Oh, Minyeop Nahm, Jinseok Park, Young-Eun Kim, Hee Kyung Jin, Jae‐sung Bae, Chang‐Seok Ki, Seung Hyun Kim
This study identifies plasma miRNA-214-3p as a biomarker predicting ALS progression speed by linking it to phagocytic dysfunction in patient-derived microglia.
bioRxiv · May 4, 2022 · PreprintNeuroscience